Clearance Summary
Invacare TDX SP2-HD with Captain's Seat received FDA 510(k) clearance under submission number K182946, sponsored by Invacare Corporation. The device was reviewed via the Special premarket notification pathway and assigned to the Physical Medicine review panel. The statutory decision date of record is 2018-12-11.
- Submission: K182946
- Applicant / Sponsor: Invacare Corporation
- Clearance pathway: Special
- Review panel: Physical Medicine
- Device class: Class II
- Regulation citation: 21 CFR 890.3860
- Decision date: 2018-12-11
Classification & Regulation
This clearance is catalogued under FDA product code ITI and 21 CFR 890.3860, within the Physical Medicine review panel as a Class II device.